Powered by: Motilal Oswal
22/06/2021 11:30:04 AM | Source: Motilal Oswal Financial Services Ltd
Neutral ITC Ltd For Target Rs.220 - Motilal Oswal
News By Tags | #872 #3525 #170 #4315 #1302
Neutral ITC Ltd For Target Rs.220 - Motilal Oswal

In line result; outlook remains uncertain

* While a better than expected performance in the Agri business led to a beat on sales, EBITDA and PBT were in line with our estimates. Volume and sales growth in Cigarettes, sales growth in FMCG – Others, as well as a full year dividend payout were broadly in line with our expectations.

* Unlike other discretionary categories, which have reported a strong rebound, two-year average growth in Cigarette volumes as well as EBIT declined by ~2% each in 4QFY21.

* While the impact of lockdowns in 1QFY22 may not be as severe as that in 1QFY21, there will be a further sequential impact compared to 4QFY21. Uncertainly on Cigarette EBIT growth, which has been below 10% for 25 of the last 27 quarters, persists. Maintain Neutral.

 

Sharp sales growth in the Agri business leads to sales beat

* Net revenue was up 22.6% YoY to INR132.9b (est. INR119.1b), EBITDA rose 7.4% to INR44.7b (in line), PBT grew 7.6% to INR48.5b (est. INR46.9b), and adjusted PAT declined 1.3% YoY to INR37.5b (est. INR34.4b) in 4QFY21 on account of a higher tax rate YoY.

* Overall gross/EBITDA margin contracted 820bp/480bp YoY to 54.3%/33.6% in 4QFY21.

* Cigarette volumes are likely to have grown ~7% (in line), although higher realizations led to 14.2% YoY growth in net sales to INR58.6b. EBIT in Cigarettes grew 7.7% YoY to INR36.7b (est. 13% growth YoY to INR38.5b). Net EBIT margin for the Cigarettes business contracted 380bp YoY to 62.6%.

* Net sales for FMCG – Others grew 15.8% YoY to INR36.9b in 4QFY21. EBIT in FMCG – Others grew 28.4% YoY to INR1.9b (v/s INR1.5b in 4QFY20).

* Revenue in the Agri business surged 78.5% YoY, while that of Paperboards, Paper, and Packaging grew 13.5%. Revenue for Hotels plunged 38.2% YoY.

* Net sales remained flat at INR454.9b in FY21. EBITDA/PAT declined 13.4%/14.6% YoY to INR155.2b/INR130.3b.

* ITC declared a final dividend of INR5.75 per share. Total dividend for the year was INR10.75 per share.

 

Valuation and view

* Changes to our model on account of the ongoing lockdowns caused by the second COVID wave in India has resulted in a 5.9%/3% reduction in our FY22E/FY23E EPS estimate. Further extensions of the lockdowns could also have an adverse effect on forecasts.

* As highlighted in our detailed note in Dec’20, with the Cigarette business likely to contribute over 82% to ITC’s overall EBIT, even in FY23E (from 85% in FY20), there is no material reduction in dependence on this segment – which is beset by concerns ranging from: a) weak EBIT growth for several years now, b) overhang of a possible GST increase going forward, and c) ESG-related issues over tobacco, leading to a reduction in valuation multiples.

* With PBT growth over FY20-23E (7.4% CAGR) likely to remain similar vis-à-vis weaker growth in the preceding five years (6.6% CAGR), valuations of 17.5x/15x FY22E/FY23E, although cheap, are fair considering the stated concerns. Dividend yield of 5-6% is expected over the next two years, in line with global Cigarette players. We continue to value ITC at a 20% premium to its global peers. Targeting 15x Jun’23E EPS, we arrive at our TP of INR220 per share. Maintain Neutral.

 

To Read Complete Report & Disclaimer Click Here

 

For More Motilal Oswal Securities Ltd Disclaimer http://www.motilaloswal.com/MOSLdisclaimer/disclaimer.html SEBI Registration number is INH000000412

 

Above views are of the author and not of the website kindly read disclaimer

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here